ID: ALA29137

Max Phase: Preclinical

Molecular Formula: C9H11FN2O4S

Molecular Weight: 262.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1c(F)cccc1S(=O)(=O)CC(N)C(=O)O

Standard InChI:  InChI=1S/C9H11FN2O4S/c10-5-2-1-3-7(8(5)12)17(15,16)4-6(11)9(13)14/h1-3,6H,4,11-12H2,(H,13,14)

Standard InChI Key:  JTBYIMAWLVROIU-UHFFFAOYSA-N

Associated Targets(non-human)

Kynureninase 17 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 262.26Molecular Weight (Monoisotopic): 262.0424AlogP: -0.41#Rotatable Bonds: 4
Polar Surface Area: 123.48Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.23CX Basic pKa: 7.73CX LogP: -3.09CX LogD: -3.24
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.63Np Likeness Score: -0.89

References

1. Drysdale MJ, Reinhard JF..  (1998)  S-aryl cysteine S,S-dioxides as inhibitors of mammalian kynureninase.,  (2): [PMID:9871640] [10.1016/s0960-894x(97)10209-8]

Source